26 November 2008

Litorina’s portfolio company Cederroth acquires Wound Care Business within Distrex S.A.

Cederoth International acquires wound care business within Distrex S.A. Through the acquisition Cederroth will strengthen its wound care business in Europe.

On November 25 2008 Cederroth International’s Spanish subsidiary Cederroth Ibérica signed an asset purchase agreement with Distrex S.A, which means that Cederroth acquires their wound care business with immediate effect. The acquired business (“Distrex”) has a turnover of approximately EUR 8.5 million p.a. and some 60 employees, mainly within maufacturing, in Bigues in the outskirts of Barcelona.

Both Cederroth and Distrex Ibérica S.A. will benefit from the transaction – Cederroth will strengten its wound care business in Europe whereas Distrex, with 30 years of experience, will focus more on pharmaceuticals and laxatives under a new company name – Laboratorios Favea. The transaction also means that there will be close contact between Cederroth and Laboratorios Favea in regard of future development projcets.

For further information, please contact:

Lars Verneholt (+46 8 545 181 80), Litorina

Litorina, founded in 1998, is a private equity firm that focuses on acquiring and industrially developing small to medium-sized primarily Swedish companies. Litorina offers broad and deep expertise via its own organization as well as through its network of industrial advisors. Litorina Capital Advisors AB acts as an investment advisor to Litorina’s third fund, Litorina Kapital III LP, which is currently in an active investment phase. Litorina is backed by a number of venerable and reputable Swedish and international institutions who have together invested approximately SEK 2,400 million in Litorina’s three funds.